Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular Mechanisms and Cellular Contribution from Lung Fibrosis to Lung Cancer Development
Anna Valeria Samarelli, Valentina Masciale, Beatrice Aramini, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 22, pp. 12179-12179
Open Access | Times Cited: 60

Showing 1-25 of 60 citing articles:

Targeting extracellular matrix stiffness and mechanotransducers to improve cancer therapy
Yangfu Jiang, Hongying Zhang, Jiao Wang, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 232
Metabolic reprogramming in cancer: Mechanisms and therapeutics
Shiqi Nong, Xiaoyue Han, Yu Xiang, et al.
MedComm (2023) Vol. 4, Iss. 2
Open Access | Times Cited: 75
Dual Relationship Between Stromal Cells and Immune Cells in the Tumor Microenvironment
Jeong-Yeon Mun, Sun‐Hee Leem, Jun‐Ho Lee, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 70
Metabolic Reprogramming in Cancer Cells: Emerging Molecular Mechanisms and Novel Therapeutic Approaches
Carla Navarro, Ángel Ortega, Raquel Santeliz, et al.
Pharmaceutics (2022) Vol. 14, Iss. 6, pp. 1303-1303
Open Access | Times Cited: 64
Drug Resistance and Endoplasmic Reticulum Stress in Hepatocellular Carcinoma
Jaafar Khaled, Maria Kopsida, Hans Lennernäs, et al.
Cells (2022) Vol. 11, Iss. 4, pp. 632-632
Open Access | Times Cited: 49
Inhibitor of PD-1/PD-L1: a new approach may be beneficial for the treatment of idiopathic pulmonary fibrosis
Jie Tan, Qianfei Xue, Xiao Hu, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7
Mechanical forces: The missing link between idiopathic pulmonary fibrosis and lung cancer
Cancan Wang, Juntang Yang
European Journal of Cell Biology (2022) Vol. 101, Iss. 3, pp. 151234-151234
Open Access | Times Cited: 29
Oxidative Stress and Lung Fibrosis: Towards an Adverse Outcome Pathway
Patrudu Makena, Tatiana Kikalova, G. L. Prasad, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12490-12490
Open Access | Times Cited: 17
The Hedgehog Signaling Pathway in Idiopathic Pulmonary Fibrosis: Resurrection Time
Wiwin Is Effendi, Tatsuya Nagano
International Journal of Molecular Sciences (2021) Vol. 23, Iss. 1, pp. 171-171
Open Access | Times Cited: 35
Theophylline Attenuates BLM-Induced Pulmonary Fibrosis by Inhibiting Th17 Differentiation
Soo-Jin Park, Hwa-Jeong Hahn, Sei‐Ryang Oh, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1019-1019
Open Access | Times Cited: 10
Circadian disruption in lung fibroblasts enhances NF‐κB activity to exacerbate neutrophil recruitment
Shannon L. Cox, James R. O’Siorain, Yan He, et al.
The FASEB Journal (2023) Vol. 37, Iss. 2
Open Access | Times Cited: 10
From Basic Research to Clinical Practice: Considerations for Treatment Drugs for Silicosis
Rou Li, Huimin Kang, Shi Chen
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 8333-8333
Open Access | Times Cited: 10
Is pulmonary fibrosis a precancerous disease?
Mahdie Hosseini, Mary Salvatore
European Journal of Radiology (2023) Vol. 160, pp. 110723-110723
Open Access | Times Cited: 8
Biophysical Control of the Glioblastoma Immunosuppressive Microenvironment: Opportunities for Immunotherapy
Landon Teer, Kavitha Yaddanapudi, Joseph Chen
Bioengineering (2024) Vol. 11, Iss. 1, pp. 93-93
Open Access | Times Cited: 2
Exploring the interplay between methylation patterns and non-coding RNAs in non-small cell lung cancer: Implications for pathogenesis and therapeutic targets
Mei Yang, Xue Hu, Bin Tang, et al.
Heliyon (2024) Vol. 10, Iss. 2, pp. e24811-e24811
Open Access | Times Cited: 2
The Effects of Endoplasmic Reticulum Stress via Intratracheal Instillation of Water-Soluble Acrylic Acid Polymer on the Lungs of Rats
Toshiki Morimoto, Hiroto Izumi, Taisuke Tomonaga, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3573-3573
Open Access | Times Cited: 2
Agent-based approaches for biological modeling in oncology: A literature review
Simon Stephan, Stéphane Galland, Ouassila Labbani, et al.
Artificial Intelligence in Medicine (2024) Vol. 152, pp. 102884-102884
Open Access | Times Cited: 2
Budding uninhibited by benzimidazoles 1 overexpression is associated with poor prognosis and malignant phenotype: A promising therapeutic target for lung adenocarcinoma
Rui Chen, Zhiping Wang, Tianzhu Lu, et al.
Thoracic Cancer (2023) Vol. 14, Iss. 10, pp. 893-912
Open Access | Times Cited: 6
Identification of the active compounds in the Yi-Fei-San-Jie formula using a comprehensive strategy based on cell extraction/UPLC-MS/MS, network pharmacology, and molecular biology techniques
Leihao Hu, Jiamin Luo, Guiqing Wen, et al.
Phytomedicine (2023) Vol. 115, pp. 154843-154843
Closed Access | Times Cited: 6
Musashi-2 in cancer-associated fibroblasts promotes non-small cell lung cancer metastasis through paracrine IL-6-driven epithelial-mesenchymal transition
Parinya Samart, Gayathri Heenatigala Palliyage, Surapol Issaragrisil, et al.
Cell & Bioscience (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 6
Nintedanib in an elderly non-small-cell lung cancer patient with severe steroid-refractory checkpoint inhibitor-related pneumonitis: A case report and literature review
Lei Pan, Fanqi Meng, Wei Wang, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 5
Proteomic profiling of formalin-fixed paraffine-embedded tissue reveals key proteins related to lung dysfunction in idiopathic pulmonary fibrosis
Anna Valeria Samarelli, Roberto Tonelli, Giulia Raineri, et al.
Frontiers in Oncology (2024) Vol. 13
Open Access | Times Cited: 1
Targeted inhibition of transforming growth factor-β type I receptor by AZ12601011 improves paraquat poisoning-induced multiple organ fibrosis
Heng Zhang, Hang Yang, Xuemei Liu, et al.
Pesticide Biochemistry and Physiology (2024) Vol. 200, pp. 105831-105831
Closed Access | Times Cited: 1
Mimosa pudica L. extract ameliorates pulmonary fibrosis via modulation of MAPK signaling pathways and FOXO3 stabilization
Quynh-Chi Nguyen, Hoang-Anh Nguyen, Tuan-Anh Nguyen Pham, et al.
Journal of Ethnopharmacology (2024) Vol. 330, pp. 118226-118226
Closed Access | Times Cited: 1
Pathology of idiopathic pulmonary fibrosis with particular focus on vascular endothelium and epithelial injury and their therapeutic potential
Wenying Lu, Alan Teoh, Maddison Waters, et al.
Pharmacology & Therapeutics (2024), pp. 108757-108757
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top